These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 28407368)

  • 21. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.
    Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F
    Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis.
    Zhao Y; Zhu L; Yang Y; Gao H; Zhang R
    Acta Clin Belg; 2023 Jun; 78(3):234-244. PubMed ID: 35913111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism.
    Novak AR; Shakowski C; Trujillo TC; Wright GC; Mueller SW; Kiser TH
    J Thromb Thrombolysis; 2022 Aug; 54(2):276-286. PubMed ID: 35689140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Elshafei MN; El-Bardissy A; Salem M; Abdelmoneim MS; Khalil A; Elhadad S; Danjuma M
    Am J Cardiovasc Drugs; 2024 Mar; 24(2):255-271. PubMed ID: 38386247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.
    Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
    Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.
    Chen J; Bi G; Wu F; Qin X
    Pediatr Res; 2023 May; 93(6):1491-1498. PubMed ID: 36071237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis.
    Elshafei MN; Mohamed MFH; El-Bardissy A; Ahmed MB; Abdallah I; Elewa H; Danjuma M
    J Thromb Thrombolysis; 2021 Feb; 51(2):388-396. PubMed ID: 32556939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
    Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A
    Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression.
    Sagris D; Leventis I; Georgiopoulos G; Korompoki E; Makaritsis K; Vemmos K; Milionis H; Lip GYH; Ntaios G
    Eur J Intern Med; 2020 Sep; 79():31-36. PubMed ID: 32409203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
    Ruff CT; Giugliano RP; Braunwald E; Hoffman EB; Deenadayalu N; Ezekowitz MD; Camm AJ; Weitz JI; Lewis BS; Parkhomenko A; Yamashita T; Antman EM
    Lancet; 2014 Mar; 383(9921):955-62. PubMed ID: 24315724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.
    Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A
    Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety Outcomes of Direct Oral Anticoagulants and Amiodarone in Patients with Atrial Fibrillation.
    Lupercio F; Romero J; Peltzer B; Maraboto C; Briceno D; Villablanca P; Ferrick K; Gross JN; Kim S; Fisher J; Di Biase L; Krumerman A
    Am J Med; 2018 May; 131(5):573.e1-573.e8. PubMed ID: 29274758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: Systematic review.
    Lee KH; Hung WT; Huang WY; Ovbiagele B; Lee M
    J Formos Med Assoc; 2024 May; 123(5):551-560. PubMed ID: 37838540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism.
    Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS
    JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease.
    Parker K; Hartemink J; Saha A; Mitra R; Lewis P; Power A; Choudhuri S; Mitra S; Thachil J
    J Nephrol; 2022 Nov; 35(8):2015-2033. PubMed ID: 36006608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.